PLUS THERAPEUTICS, INC.PSTVEarnings & Financial Report
Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system (CNS) cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecu...
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| s. AIGH Capital Management, LLC | 9.90% | 568.7K | — | 2024-06-05 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-04-01 | HEDRICK MARC H | Chief Executive Officer | Option exercise | 159.7K | $0.00 | $0 |
| 2026-04-01 | HEDRICK MARC H | Chief Executive Officer | Option grant | 201.6K | $0.00 | $0 |
| 2026-04-01 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Option exercise | 38.3K | $0.00 | $0 |
| 2026-04-01 | Sims Andrew John Hugh MacIntyre | Chief Financial Officer | Option exercise | 29.1K | $0.00 | $0 |
1–4 of 4